| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |